CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 78  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0673
LYS 10.0076
GLU 20.0115
LEU 30.0093
ARG 40.0093
CYS 50.0119
GLN 60.0134
CYS 70.0160
ILE 80.0184
LYS 90.0337
THR 100.0114
TYR 110.0050
SER 120.0230
LYS 130.0673
PRO 140.0287
PHE 150.0141
HIS 160.0475
PRO 170.0214
LYS 180.0336
PHE 190.0263
ILE 200.0196
LYS 210.0248
GLU 220.0251
LEU 230.0246
ARG 240.0236
VAL 250.0229
ILE 260.0093
GLU 270.0111
SER 280.0060
GLY 290.0080
PRO 300.0172
HIS 310.0110
CYS 320.0054
ALA 330.0067
ASN 340.0137
THR 350.0056
GLU 360.0090
ILE 370.0142
ILE 380.0193
VAL 390.0117
LYS 400.0205
LEU 410.0178
SER 420.0176
ASP 430.0122
GLY 440.0167
ARG 450.0216
GLU 460.0187
LEU 470.0089
CYS 480.0061
LEU 490.0037
ASP 500.0171
PRO 510.0200
LYS 520.0518
GLU 530.0291
ASN 540.0280
TRP 550.0318
VAL 560.0228
GLN 570.0468
ARG 580.0438
VAL 590.0150
VAL 600.0103
GLU 610.0225
LYS 620.0053
PHE 630.0127
LEU 640.0237
LYS 650.0239
ARG 660.0232
ALA 670.0439
GLU 680.0417
ASN 690.0476

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.